Hello, everyone, and welcome to the middle of the week. This means, of course, that we may be half way through the workload - or maybe not. There is always so much to do. To cope, yes, we are brewing a cup of stimluation and readying our to-do list of documents to read, notes to send and phone calls to make. We trust you relate. Meanwhile, here are some tidbits to help you along. Have a great day...
Icahn Wins One Seat On Forest Labs Board (Reuters)
Warren Buffet Cuts Stake In J&J (Bloomberg News)
Watson Sues FDA Over Generic Actos Ruling (Reuters)
Eisai CEO Sees Huge Medical Need For New Diet Drug (Dow Jones)
Roche Opens Career Center For Laid Off Workers (NorthJersey.com)
Heroin Immune Cell Offers Hope For Drug Abusers (Bloomberg News)
Boehringer Ingelheim Warns Of Difficult Outlook (Pharma Times)
Despite Alzheimer's Fears, Some Want To Know The Odds (Washington Post)
Glaxo Sells Drug Portfolio To Aspen Pharmacare (Reuters)
EDITOR'S NOTE: Please check this post for updates during the day
1 Comment